Global Endometriosis Drugs Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 19-Jul-2021
No. of pages: 108
Inquire Before Buying

Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.

Among these therapies, Elagolix, a first-in-class GnRH receptor antagonist, is closest to market.

Market Analysis and Insights: Global Endometriosis Drugs Market

The global Endometriosis Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endometriosis Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endometriosis Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endometriosis Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endometriosis Drugs market.

Global Endometriosis Drugs Scope and Market Size

Endometriosis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Endometriosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Hormonal Therapy

- Add-back Medication

- Progestogens

- Chinese Herbs

Segment by Application

- Hospitals

- Clinics

- Research Institutes

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- AbbVie

- Astellas Pharma

- AstraZeneca

- Debiopharm Group

- Evotec

- Kissei Pharmaceutical

- Neurocrine Biosciences

- ObsEva

- Pfizer

- Repros Therapeutics

- Roivant Sciences

- Takeda Pharmaceutical Company

- ValiRx

Global Endometriosis Drugs Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endometriosis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormonal Therapy
1.2.3 Add-back Medication
1.2.4 Progestogens
1.2.5 Chinese Herbs
1.3 Market by Application
1.3.1 Global Endometriosis Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Endometriosis Drugs Market Perspective (2016-2027)
2.2 Endometriosis Drugs Growth Trends by Regions
2.2.1 Endometriosis Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Endometriosis Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Endometriosis Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Endometriosis Drugs Industry Dynamic
2.3.1 Endometriosis Drugs Market Trends
2.3.2 Endometriosis Drugs Market Drivers
2.3.3 Endometriosis Drugs Market Challenges
2.3.4 Endometriosis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endometriosis Drugs Players by Revenue
3.1.1 Global Top Endometriosis Drugs Players by Revenue (2016-2021)
3.1.2 Global Endometriosis Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Endometriosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Endometriosis Drugs Revenue
3.4 Global Endometriosis Drugs Market Concentration Ratio
3.4.1 Global Endometriosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endometriosis Drugs Revenue in 2020
3.5 Endometriosis Drugs Key Players Head office and Area Served
3.6 Key Players Endometriosis Drugs Product Solution and Service
3.7 Date of Enter into Endometriosis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endometriosis Drugs Breakdown Data by Type
4.1 Global Endometriosis Drugs Historic Market Size by Type (2016-2021)
4.2 Global Endometriosis Drugs Forecasted Market Size by Type (2022-2027)
5 Endometriosis Drugs Breakdown Data by Application
5.1 Global Endometriosis Drugs Historic Market Size by Application (2016-2021)
5.2 Global Endometriosis Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Endometriosis Drugs Market Size (2016-2027)
6.2 North America Endometriosis Drugs Market Size by Type
6.2.1 North America Endometriosis Drugs Market Size by Type (2016-2021)
6.2.2 North America Endometriosis Drugs Market Size by Type (2022-2027)
6.2.3 North America Endometriosis Drugs Market Size by Type (2016-2027)
6.3 North America Endometriosis Drugs Market Size by Application
6.3.1 North America Endometriosis Drugs Market Size by Application (2016-2021)
6.3.2 North America Endometriosis Drugs Market Size by Application (2022-2027)
6.3.3 North America Endometriosis Drugs Market Size by Application (2016-2027)
6.4 North America Endometriosis Drugs Market Size by Country
6.4.1 North America Endometriosis Drugs Market Size by Country (2016-2021)
6.4.2 North America Endometriosis Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Endometriosis Drugs Market Size (2016-2027)
7.2 Europe Endometriosis Drugs Market Size by Type
7.2.1 Europe Endometriosis Drugs Market Size by Type (2016-2021)
7.2.2 Europe Endometriosis Drugs Market Size by Type (2022-2027)
7.2.3 Europe Endometriosis Drugs Market Size by Type (2016-2027)
7.3 Europe Endometriosis Drugs Market Size by Application
7.3.1 Europe Endometriosis Drugs Market Size by Application (2016-2021)
7.3.2 Europe Endometriosis Drugs Market Size by Application (2022-2027)
7.3.3 Europe Endometriosis Drugs Market Size by Application (2016-2027)
7.4 Europe Endometriosis Drugs Market Size by Country
7.4.1 Europe Endometriosis Drugs Market Size by Country (2016-2021)
7.4.2 Europe Endometriosis Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Endometriosis Drugs Market Size (2016-2027)
8.2 Asia-Pacific Endometriosis Drugs Market Size by Type
8.2.1 Asia-Pacific Endometriosis Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Endometriosis Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Endometriosis Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Endometriosis Drugs Market Size by Application
8.3.1 Asia-Pacific Endometriosis Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Endometriosis Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Endometriosis Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Endometriosis Drugs Market Size by Region
8.4.1 Asia-Pacific Endometriosis Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Endometriosis Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Endometriosis Drugs Market Size (2016-2027)
9.2 Latin America Endometriosis Drugs Market Size by Type
9.2.1 Latin America Endometriosis Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Endometriosis Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Endometriosis Drugs Market Size by Type (2016-2027)
9.3 Latin America Endometriosis Drugs Market Size by Application
9.3.1 Latin America Endometriosis Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Endometriosis Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Endometriosis Drugs Market Size by Application (2016-2027)
9.4 Latin America Endometriosis Drugs Market Size by Country
9.4.1 Latin America Endometriosis Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Endometriosis Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endometriosis Drugs Market Size (2016-2027)
10.2 Middle East & Africa Endometriosis Drugs Market Size by Type
10.2.1 Middle East & Africa Endometriosis Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Endometriosis Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Endometriosis Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Endometriosis Drugs Market Size by Application
10.3.1 Middle East & Africa Endometriosis Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Endometriosis Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Endometriosis Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Endometriosis Drugs Market Size by Country
10.4.1 Middle East & Africa Endometriosis Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Endometriosis Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Endometriosis Drugs Introduction
11.1.4 AbbVie Revenue in Endometriosis Drugs Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Endometriosis Drugs Introduction
11.2.4 Astellas Pharma Revenue in Endometriosis Drugs Business (2016-2021)
11.2.5 Astellas Pharma Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Endometriosis Drugs Introduction
11.3.4 AstraZeneca Revenue in Endometriosis Drugs Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Debiopharm Group
11.4.1 Debiopharm Group Company Details
11.4.2 Debiopharm Group Business Overview
11.4.3 Debiopharm Group Endometriosis Drugs Introduction
11.4.4 Debiopharm Group Revenue in Endometriosis Drugs Business (2016-2021)
11.4.5 Debiopharm Group Recent Development
11.5 Evotec
11.5.1 Evotec Company Details
11.5.2 Evotec Business Overview
11.5.3 Evotec Endometriosis Drugs Introduction
11.5.4 Evotec Revenue in Endometriosis Drugs Business (2016-2021)
11.5.5 Evotec Recent Development
11.6 Kissei Pharmaceutical
11.6.1 Kissei Pharmaceutical Company Details
11.6.2 Kissei Pharmaceutical Business Overview
11.6.3 Kissei Pharmaceutical Endometriosis Drugs Introduction
11.6.4 Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2016-2021)
11.6.5 Kissei Pharmaceutical Recent Development
11.7 Neurocrine Biosciences
11.7.1 Neurocrine Biosciences Company Details
11.7.2 Neurocrine Biosciences Business Overview
11.7.3 Neurocrine Biosciences Endometriosis Drugs Introduction
11.7.4 Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2016-2021)
11.7.5 Neurocrine Biosciences Recent Development
11.8 ObsEva
11.8.1 ObsEva Company Details
11.8.2 ObsEva Business Overview
11.8.3 ObsEva Endometriosis Drugs Introduction
11.8.4 ObsEva Revenue in Endometriosis Drugs Business (2016-2021)
11.8.5 ObsEva Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Endometriosis Drugs Introduction
11.9.4 Pfizer Revenue in Endometriosis Drugs Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Repros Therapeutics
11.10.1 Repros Therapeutics Company Details
11.10.2 Repros Therapeutics Business Overview
11.10.3 Repros Therapeutics Endometriosis Drugs Introduction
11.10.4 Repros Therapeutics Revenue in Endometriosis Drugs Business (2016-2021)
11.10.5 Repros Therapeutics Recent Development
11.11 Roivant Sciences
11.11.1 Roivant Sciences Company Details
11.11.2 Roivant Sciences Business Overview
11.11.3 Roivant Sciences Endometriosis Drugs Introduction
11.11.4 Roivant Sciences Revenue in Endometriosis Drugs Business (2016-2021)
11.11.5 Roivant Sciences Recent Development
11.12 Takeda Pharmaceutical Company
11.12.1 Takeda Pharmaceutical Company Company Details
11.12.2 Takeda Pharmaceutical Company Business Overview
11.12.3 Takeda Pharmaceutical Company Endometriosis Drugs Introduction
11.12.4 Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2016-2021)
11.12.5 Takeda Pharmaceutical Company Recent Development
11.13 ValiRx
11.13.1 ValiRx Company Details
11.13.2 ValiRx Business Overview
11.13.3 ValiRx Endometriosis Drugs Introduction
11.13.4 ValiRx Revenue in Endometriosis Drugs Business (2016-2021)
11.13.5 ValiRx Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Endometriosis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormonal Therapy
Table 3. Key Players of Add-back Medication
Table 4. Key Players of Progestogens
Table 5. Key Players of Chinese Herbs
Table 6. Global Endometriosis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Endometriosis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Endometriosis Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Endometriosis Drugs Market Share by Regions (2016-2021)
Table 10. Global Endometriosis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Endometriosis Drugs Market Share by Regions (2022-2027)
Table 12. Endometriosis Drugs Market Trends
Table 13. Endometriosis Drugs Market Drivers
Table 14. Endometriosis Drugs Market Challenges
Table 15. Endometriosis Drugs Market Restraints
Table 16. Global Endometriosis Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Endometriosis Drugs Market Share by Players (2016-2021)
Table 18. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Drugs as of 2020)
Table 19. Ranking of Global Top Endometriosis Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Endometriosis Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Endometriosis Drugs Product Solution and Service
Table 23. Date of Enter into Endometriosis Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Endometriosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Endometriosis Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Endometriosis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Endometriosis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Endometriosis Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Endometriosis Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Endometriosis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Endometriosis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Endometriosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Endometriosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Endometriosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Endometriosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Endometriosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Endometriosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Endometriosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Endometriosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Endometriosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Endometriosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Endometriosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Endometriosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Endometriosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Endometriosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Endometriosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Endometriosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Endometriosis Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Endometriosis Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Endometriosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Endometriosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Endometriosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Endometriosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Endometriosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Endometriosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Endometriosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Endometriosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Endometriosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Endometriosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Endometriosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Endometriosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Endometriosis Drugs Product
Table 66. AbbVie Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Astellas Pharma Company Details
Table 69. Astellas Pharma Business Overview
Table 70. Astellas Pharma Endometriosis Drugs Product
Table 71. Astellas Pharma Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 72. Astellas Pharma Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Endometriosis Drugs Product
Table 76. AstraZeneca Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Debiopharm Group Company Details
Table 79. Debiopharm Group Business Overview
Table 80. Debiopharm Group Endometriosis Drugs Product
Table 81. Debiopharm Group Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 82. Debiopharm Group Recent Development
Table 83. Evotec Company Details
Table 84. Evotec Business Overview
Table 85. Evotec Endometriosis Drugs Product
Table 86. Evotec Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 87. Evotec Recent Development
Table 88. Kissei Pharmaceutical Company Details
Table 89. Kissei Pharmaceutical Business Overview
Table 90. Kissei Pharmaceutical Endometriosis Drugs Product
Table 91. Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 92. Kissei Pharmaceutical Recent Development
Table 93. Neurocrine Biosciences Company Details
Table 94. Neurocrine Biosciences Business Overview
Table 95. Neurocrine Biosciences Endometriosis Drugs Product
Table 96. Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 97. Neurocrine Biosciences Recent Development
Table 98. ObsEva Company Details
Table 99. ObsEva Business Overview
Table 100. ObsEva Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 101. ObsEva Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Endometriosis Drugs Product
Table 105. Pfizer Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 106. Pfizer Recent Development
Table 107. Repros Therapeutics Company Details
Table 108. Repros Therapeutics Business Overview
Table 109. Repros Therapeutics Endometriosis Drugs Product
Table 110. Repros Therapeutics Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 111. Repros Therapeutics Recent Development
Table 112. Roivant Sciences Company Details
Table 113. Roivant Sciences Business Overview
Table 114. Roivant Sciences Endometriosis Drugs Product
Table 115. Roivant Sciences Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 116. Roivant Sciences Recent Development
Table 117. Takeda Pharmaceutical Company Company Details
Table 118. Takeda Pharmaceutical Company Business Overview
Table 119. Takeda Pharmaceutical Company Endometriosis Drugs Product
Table 120. Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 121. Takeda Pharmaceutical Company Recent Development
Table 122. ValiRx Company Details
Table 123. ValiRx Business Overview
Table 124. ValiRx Endometriosis Drugs Product
Table 125. ValiRx Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 126. ValiRx Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endometriosis Drugs Market Share by Type: 2020 VS 2027
Figure 2. Hormonal Therapy Features
Figure 3. Add-back Medication Features
Figure 4. Progestogens Features
Figure 5. Chinese Herbs Features
Figure 6. Global Endometriosis Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Endometriosis Drugs Report Years Considered
Figure 11. Global Endometriosis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Endometriosis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Endometriosis Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Endometriosis Drugs Market Share by Regions (2022-2027)
Figure 15. Global Endometriosis Drugs Market Share by Players in 2020
Figure 16. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Endometriosis Drugs Revenue in 2020
Figure 18. Global Endometriosis Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Endometriosis Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Endometriosis Drugs Market Share by Type (2016-2027)
Figure 22. North America Endometriosis Drugs Market Share by Application (2016-2027)
Figure 23. North America Endometriosis Drugs Market Share by Country (2016-2027)
Figure 24. United States Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Endometriosis Drugs Market Share by Type (2016-2027)
Figure 28. Europe Endometriosis Drugs Market Share by Application (2016-2027)
Figure 29. Europe Endometriosis Drugs Market Share by Country (2016-2027)
Figure 30. Germany Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Endometriosis Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Endometriosis Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Endometriosis Drugs Market Share by Region (2016-2027)
Figure 40. China Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Endometriosis Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Endometriosis Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Endometriosis Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Endometriosis Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Endometriosis Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Endometriosis Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AbbVie Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 60. Astellas Pharma Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 62. Debiopharm Group Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 63. Evotec Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 64. Kissei Pharmaceutical Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 65. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 66. ObsEva Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 68. Repros Therapeutics Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 69. Roivant Sciences Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 70. Takeda Pharmaceutical Company Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 71. ValiRx Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
  • Global Endometriosis Drugs Market Size, Status and Forecast 2021-2027
    Published: 19-Jul-2021        Price: US 3900 Onwards        Pages: 108
    Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years. Among these therapies, Elagolix, a first-in-class GnRH receptor antagonist, is closest to market. Market Analysis and Insights: Global Endometriosis Drugs Market The global Endometriosis Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high d......
  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2021-2026
    Published: 16-Jul-2021        Price: US 3660 Onwards        Pages: 101
    According to this latest study, the 2021 growth of Drugs for Vulvovaginal Candidiasis will have significant change from previous year. By the most conservative estimates of global Drugs for Vulvovaginal Candidiasis market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 787 million in 2020. Over the next five years the Drugs for Vulvovaginal Candidiasis market will register a 1.6% CAGR in terms of revenue, the global market size will reach US$ 837.......
  • Cervical Intraepithelial Neoplasia (CIN) - Global Clinical Trials Review, H2, 2021
    Published: 15-Jul-2021        Price: US 2500 Onwards        Pages: 148
    Cervical Intraepithelial Neoplasia (CIN) - Global Clinical Trials Review, H2, 2021 Summary GlobalData's clinical trial report, "Cervical Intraepithelial Neoplasia (CIN) - Global Clinical Trials Review, H2, 2021" provides an overview of Cervical Intraepithelial Neoplasia (CIN) Clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Intraepithelial Neoplasia (CIN). Report includes an overview of trial numbers and their aver......
  • Global Assisted Reproductive Technology Market Size, Status and Forecast 2021-2027
    Published: 13-Jul-2021        Price: US 3900 Onwards        Pages: 108
    Assisted reproductive technology (ART) is a wide range of procedures that are used to treat infertility in men and women. Generally, ART procedures include techniques, such as IVF, ZIFT, GIFT, ICSI, and artificial insemination, which help individuals to conceive a child. The analysts forecast the global assisted reproductive technology market to grow at a CAGR of 4.11% during the period 2017-2021. Market Analysis and Insights: Global Assisted Reproductive Technology Market......
  • Global Drugs for Vulvovaginal Candidiasis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 13-Jul-2021        Price: US 5900 Onwards        Pages: 121
    The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after ......
  • Topical Contraceptive Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type
    Published: 11-Jul-2021        Price: US 3200 Onwards        Pages: 109
    This report describes the global market size of Topical Contraceptive from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also in......
  • Oral Contraceptive Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type
    Published: 11-Jul-2021        Price: US 3200 Onwards        Pages: 127
    This report describes the global market size of Oral Contraceptive from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also inclu......
  • 2021-2030 Report on Global Bacterial Vaginosis Drug Market by Player, Region, Type, Application and Sales Channel
    Published: 10-Jul-2021        Price: US 2500 Onwards        Pages: 120
    This report studies the Bacterial Vaginosis Drug market, covering market size for segment by type (Rx, OTC, etc.), by application (Hospital, Pharmacy, etc.), by Sales Channel (Direct Channel, Distribution Channel), by player (Bayer, Pfizer, Sanofi, Piramal, Abbott, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). Since the pandemic of COVID-19 is still raging, The COVID-19 will have a certain impact on this global market. This rese......
  • Global Human Chorionic Gonadotropin Market Size, Status and Forecast 2021-2027
    Published: 09-Jul-2021        Price: US 3900 Onwards        Pages: 99
    Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta. hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men. hCG triggers ovulation in women and assists in increasing the sperm count in men. Market Analysis and Insights: Global Human Chorionic Gonadotropin Market The global Huma......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs